BACKGROUND AND OBJECTIVE: Patient selection criteria and experimental interventions of randomized controlled trials may not reflect how things work in practice. The aim of this study was to describe the characteristics of chronic obstructive pulmonary disease (COPD) patients undergoing an inpatient pulmonary rehabilitation program (PRP) and the correlates of success. METHODS: Retrospective database review of 975 consecutive patients transferred from acute care hospitals after an acute exacerbation (group A: 14.6%) or admitted from home (group B: 75.4%), from 2010 to 2017. Patients were also divided according to the associated registered main diagnosis: COPD (group 1: 30.6%); COPD and respiratory failure (group 2: 51.7%); COPD and obstructive sleep apnea (group 3: 17.6%). Baseline correlates of post-PRP changes in six minute walking test (6MWT) were also evaluated. RESULTS: Global Initiative for Chronic Obstructive Lung Disease stages 3 and 4 were the most commonly represented in group 2 (p=0.0001). Comorbidity Index of all patients was 3.9±1.8. The overall in-hospital mortality rate was 1.3% (5.6% vs 0.6%, in groups A and B, respectively; p=0.0001). Hypertension, cardiac diseases and obesity were observed in 65.2, 52.2 and 29.6% of patients, respectively. Post-PRP 6MWT increased in all groups. Age, male gender, airway obstruction and baseline 6MWT were correlated with a post-PRP 30 meter increase in 6MWT. CONCLUSION: Confirming data of literature, this real-life study shows the characteristics of COPD patients undergoing an inpatient PRP with significant improvement in exercise capacity, independent of whether in stable state or after a recent exacerbation or of the associated main diagnosis.
BACKGROUND AND OBJECTIVE:Patient selection criteria and experimental interventions of randomized controlled trials may not reflect how things work in practice. The aim of this study was to describe the characteristics of chronic obstructive pulmonary disease (COPD) patients undergoing an inpatient pulmonary rehabilitation program (PRP) and the correlates of success. METHODS: Retrospective database review of 975 consecutive patients transferred from acute care hospitals after an acute exacerbation (group A: 14.6%) or admitted from home (group B: 75.4%), from 2010 to 2017. Patients were also divided according to the associated registered main diagnosis: COPD (group 1: 30.6%); COPD and respiratory failure (group 2: 51.7%); COPD and obstructive sleep apnea (group 3: 17.6%). Baseline correlates of post-PRP changes in six minute walking test (6MWT) were also evaluated. RESULTS: Global Initiative for Chronic Obstructive Lung Disease stages 3 and 4 were the most commonly represented in group 2 (p=0.0001). Comorbidity Index of all patients was 3.9±1.8. The overall in-hospital mortality rate was 1.3% (5.6% vs 0.6%, in groups A and B, respectively; p=0.0001). Hypertension, cardiac diseases and obesity were observed in 65.2, 52.2 and 29.6% of patients, respectively. Post-PRP 6MWT increased in all groups. Age, male gender, airway obstruction and baseline 6MWT were correlated with a post-PRP 30 meter increase in 6MWT. CONCLUSION: Confirming data of literature, this real-life study shows the characteristics of COPDpatients undergoing an inpatient PRP with significant improvement in exercise capacity, independent of whether in stable state or after a recent exacerbation or of the associated main diagnosis.
Authors: Michele Vitacca; Mara Paneroni; Alberto Braghiroli; Bruno Balbi; Maria Aliani; Patrizia Guido; Francesco Fanfulla; Mario Pertosa; Piero Ceriana; Elisabetta Zampogna; Rita Raccanelli; Nicola Sarno; Antonio Spanevello; Mauro Maniscalco; Alberto Malovini; Nicolino Ambrosino Journal: J Clin Sleep Med Date: 2020-04-15 Impact factor: 4.062
Authors: Carla Simonelli; Michele Vitacca; Nicolino Ambrosino; Simonetta Scalvini; Francesca Rivadossi; Manuela Saleri; Aubin G Fokom; Ilaria Speltoni; Riccardo Ghirardi; Mara Paneroni Journal: Int J Environ Res Public Health Date: 2020-02-05 Impact factor: 3.390
Authors: Michele Vitacca; Mara Paneroni; Alberto Malovini; Annalisa Carlucci; Chiara Binda; Vincenzo Sanci; Nicolino Ambrosino Journal: Int J Environ Res Public Health Date: 2021-11-12 Impact factor: 3.390
Authors: Elisabetta Zampogna; Nicolino Ambrosino; Laura Saderi; Giovanni Sotgiu; Paola Bottini; Patrizia Pignatti; Rosella Centis; Giovanni Battista Migliori; Antonio Spanevello; Martina Zappa; Dina Visca Journal: J Bras Pneumol Date: 2021-07-19 Impact factor: 2.624